Investors Hub Daily
|
Home
|
Log in
Boards
Stocks
Commodities
Forex
The Lounge
Hot!
Breakout Boards
iHub My Stocks Activity
Ticker Buzz Cloud
Top Boards
Most Read
Most Posted
Most Followed Members
Recent News
Active Boards
Site Stats
New Boards
Hot on StockWiki
Data Tools
Charts
Trader Alerts
Trades
Portfolio
Top Lists
News Alerts
Commodities
More Tools
My Image Gallery
Advanced Search
Videos
All News
Stock Screener
News Filter
Live Charts
Live News
Live Desktop
Forex Prices
Commodities
ETF Center
Online Brokers
Educational Channel
Streamer
Level 2
Home
>
Boards
>
Free Zone
>
Health and Sciences
>
Biotech Values
Royal DSM acquires MATK for $31.50/sh in cash,
Public Reply
|
Private Reply
|
Keep
|
Last Read
Post New Msg
Next 10
|
Previous
|
Next
DewDiligence
Tuesday, December 21, 2010 1:50:10 AM
Re:
ThomasS
post# 82169
Post #
of
161543
Royal DSM acquires MATK for $31.50/sh in cash, a 35% premium to Monday’s closing price:
http://finance.yahoo.com/news/DSM-to-Acquire-Martek-to-Add-prnews-3207228334.html?x=0&.v=1
CC at 3:30am ET (9:30am local time).
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Public Reply
|
Private Reply
|
Keep
|
Last Read
Post New Msg
Next 10
|
Previous
|
Next
Follow Board
Keyboard Shortcuts
Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote
-
Discussion Board
+/- to Watchlist
© 2013 InvestorsHub.Com, Inc.